US Patent Issued to Anwita Biosciences on March 4 for "Interleukin-22 fusion proteins, and their pharmaceutical compositions" (California Inventors)

ALEXANDRIA, Va., March 5 -- United States Patent no. 12,240,879, issued on March 4, was assigned to Anwita Biosciences Inc. (San Carlos, Calif.).

"Interleukin-22 fusion proteins, and their pharmaceutical compositions" was invented by Ziyang Zhong (Belmont, Calif.), Fan Ye (Mountain View, Calif.), Jianing Huang (San Mateo, Calif.), Matthew Siegel (Menlo Park, Calif.) and Ji Wang (Castro Valley, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are a fusion protein comprising an interleukin-22 domain and an albumin binding domain, and a pharmaceutical composition thereof. Also provided herein are methods of their use for treating, preventing, or ameliorating one or more symptoms of an infla...